晨光生物(300138) - 2025 Q1 - 季度业绩预告

Financial Performance Expectations - The company expects net profit attributable to shareholders to be between 90 million and 120 million yuan, representing a year-on-year increase of 133.21% to 210.95%[5] - The net profit after deducting non-recurring gains and losses is projected to be between 75 million and 105 million yuan, an increase of 54.68% to 116.55% compared to the same period last year[5] - The estimated impact of non-recurring gains and losses on net profit is approximately 15 million yuan[6] Business Performance Drivers - The growth in performance is attributed to the strong performance of the plant extraction business, which serves as the company's "cornerstone" for growth[6] - The cottonseed-related products have turned profitable due to the recovery in the prices of bulk commodities such as soybean oil and soybean meal[6] Future Reporting - The specific financial data for Q1 2025 will be detailed in the company's Q1 2025 report[6]